T. Rutherford

发表

Mitochondria: The ketogenic diet--A metabolism-based therapy.

W. Sperl, B. Kofler, R. Feichtinger, 2015, The international journal of biochemistry & cell biology.

Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium‐chain triglyceride ketogenic diet

S. Heales, S. Eaton, M. Orford, 2017, Epilepsia.

Putative adjunct therapies to target mitochondrial dysfunction and oxidative stress in phenylketonuria, lysosomal storage disorders and peroxisomal disorders

I. Hargreaves, Tricia Rutherford, Nadia Turton, 2020 .

The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome

S. Rahman, S. Heales, E. Fassone, 2016, Journal of Inherited Metabolic Disease.

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model

W. Sperl, B. Kofler, J. Mayr, 2017, Oncotarget.

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

W. Sperl, B. Kofler, R. Feichtinger, 2017, Oncotarget.

Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome

S. Eaton, C. Reid, S. Petrou, 2021, Epilepsia.

The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells

J. Cross, S. Rahman, S. Heales, 2014, Journal of neurochemistry.

Protective effects of MCT diet in a mouse model of Dravet syndrome

C. Reid, S. Petrou, Melody Li, 2021 .

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy

S. Eaton, M. Walker, S. Sisodiya, 2021, Brain communications.

SH-SY5Y cells undergo changes in peroxisomal metabolism when exposed to decanoic acid.

T. Rutherford, Simon Eaton, Simon Heales, 2024, Journal of neurochemistry.